Guerbet - Medical Imaging Europe Solutions/Service Company
healthcaretechoutlook

Guerbet : Diagnostic Imaging Interconnected Solution

Follow Guerbet on :

David Hale,  CEO , Guerbet David Hale, CEO , Guerbet
Over the years, to meet the rising diagnostic requirements and improve sales volume, vendors focus on developing technologically advanced medical digital imaging systems with features such as 5D ultrasound and digital X-rays with wireless DR detectors. These developments, coupled with the focus of vendors on integrating their imaging modalities with enhanced software solutions, have positively influenced the growth of the market. Today, artificial intelligence and machine learning have also emerged as one of the key medical imaging market trends that have gained traction over the forecast period. The AI-enabled medical imaging allows users to automate and standardize complex diagnostic procedures, improve patient experience outcomes, and reduce costs. In addition, vendors are also developing AI platforms for end-users such as hospitals to manage medical imaging data and help clinicians in making quick and accurate diagnosis decisions. Since 1926, Guerbet, the French pharmaceutical group, has been pioneering diagnostic and interventional imaging. The company is a leader in developing medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging. Guerbet exerts total control over the entire range of its processes, from Research & Development to distribution.

Driven by its commitment to advance radiology —Guerbet Diagnostic Imaging has designed a portfolio of interconnected contrast imaging solutions that enhance decision-making at every point of the patient journey from diagnosis, treatment to follow-up in order to focus on efficiently improving patient outcomes.


UNIK is an innovative solution designed to create additional value that extends beyond our individual products

Guerbet’s UNIK platform is a flexible solution tailored to a user’s specific challenges and requirements, designed to additional value at each step of the patient healthcare journey. It interconnects the company’s comprehensive portfolio of products, solutions, and services in diagnostic imaging on a single platform. UNIK offers high-quality contrast media for enhanced clinical decision-making. The platform also connects the smart injection solutions for safe and efficient injections, including OptiVantage, Illumena Néo, FlowSens, and OptiStar Elite. Furthermore, for heightened patient safety and productivity, it combines the to facilitate monitoring and tracking of patient injection data and contrast media with Guerbet’s Contrast&Care solution.”UNIK is an innovative solution designed to create additional value that extends beyond our individual products,” - David Hale, CEO of Guerbet.

Since the creation of its very first product in 1901 by Dr. Marcel Guerbe, the company has been striving towards the highest level of safety, quality, and efficiency in the medical imaging market.

More than 100 years after its discovery, innovation irrigates all Guerbet’s decisions and actions.

The company invests in Research and Development continuously in order to improve its existing products and pioneer newer ones to meet unmet medical needs. To reach its Research and Development targets, Guerbet is building a strategy of partnership and collaboration agreements.

In addition, the company has collaborated with numerous start-ups, major companies, centers of excellence, academic organizations, hospitals, and leading actors within the sector to spearhead new concepts in the world of healthcare. “Our company is determined to assume the responsibility to enhance the quality of life of patients at our level around the world,” - David Hale, CEO of Guerbet.

Share this Article:
Top 10 Medical Imaging Solution Companies in Europe - 2021

Company
Guerbet

Headquarters
Paris, France

Management
David Hale, CEO , Guerbet

Description
Since 1926, Guerbet, the French pharmaceutical group, has been pioneering diagnostic and interventional imaging. The company is a leader in developing medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging. Guerbet exerts total control over the entire range of its processes, from Research & Development to distribution. The company has collaborated with numerous start-ups, major companies, centers of excellence, academic organizations, hospitals, and leading actors within the sector to spearhead new concepts in the world of healthcare.